Enzymatic profiling of human kallikrein 14 using phage-display substrate technology von Felber, Loyse M., Borgoño, Carla A., Cloutier, Sylvain M., Kündig, Christoph, Kishi, Tadaaki, Chagas, Jair Ribeiro, Jichlinski, Patrice, Gygi, Christian M., Leisinger, Hans-Jürg, Diamandis, Eleftherios P., Deperthes, David

Volltext

Evaluation of the CFP-substrate-YFP system for protease studies: advantages and limitations von Felber, Loyse M, Cloutier, Sylvain M, Kündig, Christoph, Kishi, Tadaaki, Brossard, Vincent, Jichlinski, Patrice, Leisinger, Hans-Jürg, Deperthes, David

Volltext

Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14 von Felber, Loyse M., Kündig, Christoph, Borgoño, Carla A., Chagas, Jair R., Tasinato, Andrea, Jichlinski, Patrice, Gygi, Christian M., Leisinger, Hans‐Jürg, Diamandis, Eleftherios P., Deperthes, David, Cloutier, Sylvain M.

Volltext

Peptabody‐EGF: A novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells von Fattah, Omar M., Cloutier, Sylvain M., Kündig, Christoph, Felber, Loyse M., Gygi, Christian M., Jichlinski, Patrice, Leisinger, Hans‐Jürg, Gauthier, Eric R., Mach, Jean Pierre, Deperthes, David

Volltext

Development of recombinant inhibitors specific to human kallikrein 2 using phage‐display selected substrates von Cloutier, Sylvain M., Kündig, Christoph, Felber, Loyse M., Fattah, Omar M., Chagas, Jair R., Gygi, Christian M., Jichlinski, Patrice, Leisinger, Hans‐Jürg, Deperthes, David

Volltext

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study von Musallam, Khaled M, Taher, Ali T, Kattamis, Antonis, Cappellini, Maria Domenica, Lord-Bessen, Jennifer, Glassberg, Mrudula, Pelligra, Christopher, Guo, Shien, Felber Medlin, Loyse, Moro Bueno, Luciana, Kuo, Kevin H.M.

Volltext